Opendata, web and dolomites


Artificial Intelligence to transform Drug and Chemical safety testing

Total Cost €


EC-Contrib. €






 PATH-TOX project word cloud

Explore the words cloud of the PATH-TOX project. It provides you a very rough idea of what is the project "PATH-TOX" about.

customers    manually    trained    prototype    deciphex    sme    validation    pathologists    competition    worldwide    individual    diagnostic    accelerate    streamline    risky    tests    normal    intelligence    competitors    workflow    manual    image    lack    cros    direct    framework    led    expensive    pathological    janssen    computer    routinely    undergo    looming    data    thousands    global    drugs    ltd    ai    liver    animals    performance    time    crisis    pathologist    sections    perform    discovery    fit    tox    veterinary    date    belgium    interface    tools    market    purpose    optimise    pharma    tissue    pharmaceuticals    markets    toxicity    mainly    compare    irish    tissues    automatically    regards    aided    toxicology    components    drug    artificial    abnormal    knock    reducing    effect    swiss    once    benchmarking    upfront    review    solutions    yields    expand    patholytix    big    cloud    engine    consuming    hence    safety    animal    pathology   

Project "PATH-TOX" data sheet

The following table provides information about the project.


Organization address
city: BEERSE
postcode: 2340

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 2˙935˙000 €
 EC max contribution 2˙054˙499 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JANSSEN PHARMACEUTICA NV BE (BEERSE) coordinator 134˙531.00
2    DECIPHEX LIMITED IE (MORNINGTON MEATH) participant 1˙626˙843.00
3    PDS PATHOLOGY DATA SYSTEMS AG CH (PRATTEIN) participant 293˙125.00


 Project objective

Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which yields thousands of tissue sections that currently must be assessed manually by a trained veterinary pathology. However, there is a looming crisis due to the lack pathologists.

The PATH-TOX consortium is led by Irish SME, Deciphex Ltd, and includes key partners such as Janssen Pharmaceuticals in Belgium and Pathology Data Systems Ltd a Swiss based SME. They are creating PATHOLYTIX-TOX a computer aided diagnostic system to streamline the pathology review process. Using state-of-the-art artificial intelligence (AI) image analysis tools it will automatically identify the normal and abnormal tissues upfront, allowing the pathologist to focus mainly on the abnormal cases, hence accelerate workflow.

To date, we have built a working prototype of the image analysis engine, which can identify abnormal tissue in liver. In this project we will optimise the engine further to improve performance and expand its use into other tissues. We will also develop other features such as the user interface, data management and cloud framework. Once developed, we will perform a comprehensive validation and benchmarking study to compare to manual pathology assessment.

There is a large, growing, global target market for PATHOLYTIX-TOX. Pharma and CROs worldwide routinely perform thousands of animal toxicology tests each year, who are potential customers. With regards to competitors, there is no direct competition. Competitors offer individual components of the pathological workflow, not fit-for-purpose solutions for the toxicology pathology market.

Overall, PATHOLYTIX would have a big impact on drug development, by reducing the time required for pathology review and associated costs. This should have a knock on effect for the global and EU markets, reducing time and cost for new drugs to get to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PATH-TOX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PATH-TOX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

BIOSNAP (2019)


Read More  

GoSafe (2019)

Restoring complete sensory ability for natural walking of amputees

Read More  

GIoT (2019)

Nano-satellites based Global Infrastructure to Enable IoT/M2M Networks - GIoT (Global IoT)

Read More